drugset / Trial / NCT00384046

Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen

NCT00384046

Phase 3 Completed 272 enrolled Warner Chilcott
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine whether the transdermal testosterone system (TTS) is effective and safe in the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women who are on transdermal estrogen.

Timeline

Start
2006-11
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 300 ug Other